Safely Discontinuing Lamotrigine
Lamotrigine should be discontinued gradually over a period of at least 4 weeks, reducing the dose by 25-33% of the original dose every week to minimize withdrawal symptoms and seizure risk. 1
Rationale for Gradual Tapering
Lamotrigine requires careful discontinuation due to several important factors:
- Abrupt discontinuation may increase the risk of seizures, even in patients taking lamotrigine for mood disorders rather than epilepsy 1
- The brain needs time to readjust to the absence of lamotrigine's effects on voltage-sensitive sodium channels and neurotransmitter release 1
- Withdrawal symptoms may occur with rapid discontinuation 2
Standard Tapering Schedule
For a typical patient on lamotrigine (example using 300mg daily dose):
- Week 1: Reduce to 200mg daily (approximately 33% reduction)
- Week 2: Reduce to 150mg daily (50% of original dose)
- Week 3: Reduce to 100mg daily
- Week 4: Reduce to 50mg daily
- Week 5: Discontinue completely
Special Considerations
Higher Risk Patients
For patients at higher risk of adverse effects from discontinuation, consider a more gradual taper:
- 6-8 week taper with 25% reductions every 2 weeks
- Weekly reductions of smaller increments (e.g., 50mg per week) 1
Drug Interactions
- If the patient is also taking enzyme-inducing medications (like carbamazepine, phenytoin, or oxcarbazepine), be aware that discontinuing these medications while continuing lamotrigine can lead to increased lamotrigine levels and potential toxicity 3
- Conversely, if discontinuing lamotrigine while continuing valproate, remember that valproate decreases lamotrigine clearance, so tapering may need to be more gradual 4
Monitoring During Tapering
During the tapering period, patients should be monitored for:
- Emergence of seizures (if lamotrigine was prescribed for epilepsy)
- Mood symptoms (if prescribed for bipolar disorder) 5
- Withdrawal symptoms including anhedonia, tremor, tachycardia, and hyperhydrosis 2
Potential Complications to Watch For
- Withdrawal syndrome: Characterized by psychomotor inhibition, anhedonia, tremor, tachycardia, and excessive sweating 2
- Seizure recurrence: Particularly in patients with epilepsy
- Mood destabilization: In patients with bipolar disorder 5
- Rare but serious adverse effects: While uncommon, be vigilant for any signs of Stevens-Johnson syndrome, which can occur with lamotrigine use 6
Common Pitfalls to Avoid
- Tapering too quickly: This increases risk of withdrawal symptoms and seizure recurrence
- Failing to adjust for drug interactions: Particularly important when multiple antiepileptic drugs are involved
- Inadequate monitoring: Patients should be informed about potential withdrawal symptoms and instructed to report concerning symptoms immediately
- Discontinuing in high-risk settings: Avoid initiating discontinuation before major life events or periods of high stress
By following a structured tapering schedule and monitoring patients closely, lamotrigine can be safely discontinued while minimizing the risk of adverse effects or symptom recurrence.